Chantix, Psychiatric Risks and the FDA
In a recently released Public Health Advisory, the U.S. Food and Drug Administration (FDA) issued a second alert to the public about severe psychiatric side-effects linked to the smoking-cessation drug, Chantix.[1] Back in November 2006 when the FDA published its initial findings, they were only able to state a potential-but still... Read more
